 Substance P
"Substance P" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses.
| Descriptor ID |
D013373
|
| MeSH Number(s) |
D12.644.276.812.900.866 D12.644.400.800.750 D12.644.456.800.866 D12.776.467.812.900.866 D12.776.641.650.800.750 D23.469.050.375.850.890 D23.529.812.900.866
|
| Concept/Terms |
Substance P- Substance P
- P, Substance
- Euler-Gaddum Substance P
- Euler Gaddum Substance P
- P, Euler-Gaddum Substance
- Substance P, Euler-Gaddum
- SP(1-11)
|
Below are MeSH descriptors whose meaning is more general than "Substance P".
Below are MeSH descriptors whose meaning is more specific than "Substance P".
This graph shows the total number of publications written about "Substance P" by people in UAMS Profiles by year, and whether "Substance P" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 0 | 1 | 1 | | 2021 | 1 | 0 | 1 | | 2018 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2006 | 0 | 1 | 1 | | 2005 | 1 | 0 | 1 | | 2004 | 1 | 1 | 2 | | 2002 | 0 | 1 | 1 | | 2001 | 2 | 0 | 2 | | 2000 | 1 | 0 | 1 | | 1999 | 2 | 0 | 2 | | 1998 | 0 | 1 | 1 | | 1997 | 1 | 0 | 1 | | 1996 | 0 | 1 | 1 | | 1994 | 1 | 0 | 1 | | 1991 | 1 | 1 | 2 | | 1989 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Substance P" by people in Profiles over the past ten years.
-
Singh RB, Naderi A, Cho W, Ortiz G, Musayeva A, Dohlman TH, Chen Y, Ferrari G, Dana R. Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders. Ocul Surf. 2022 07; 25:142-153.
-
Widiapradja A, Kasparian AO, McCaffrey SL, Kolb LL, Imig JD, Lacey JL, Melendez GC, Levick SP. Replacement of Lost Substance P Reduces Fibrosis in the Diabetic Heart by Preventing Adverse Fibroblast and Macrophage Phenotype Changes. Cells. 2021 10 05; 10(10).
-
Mouritzen MV, Abourayale S, Ejaz R, Ardon CB, Carvalho E, Dalgaard LT, Roursgaard M, Jenssen H. Neurotensin, substance P, and insulin enhance cell migration. J Pept Sci. 2018 Jul; 24(7):e3093.
-
Leal EC, Carvalho E, Tellechea A, Kafanas A, Tecilazich F, Kearney C, Kuchibhotla S, Auster ME, Kokkotou E, Mooney DJ, LoGerfo FW, Pradhan-Nabzdyk L, Veves A. Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype. Am J Pathol. 2015 Jun; 185(6):1638-48.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|